Estimates Revisions Tempus AI, Inc. Buenos Aires S.E.

Stocks

End-of-day quote Buenos Aires S.E. 2026-09-28			5-day change	1st Jan Change
11,460.00 ^ARS	+0.09%		+10.72%	+49.80%

09-28	Tempus AI, Inc. Receives FDA Clearance For Tempus ECG-MR AI Product Designed To Identify Undiagnosed Mitral Regurgitation	CI
09-28	Tempus AI Receives FDA Clearance for ECG-MR Tool to Identify Moderate or Severe Mitral Regurgitation	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	LONZA GROUP AG
	IQVIA HOLDINGS INC.
	REVOLUTION MEDICINES, INC.
	BEONE MEDICINES AG
	CELLTRION, INC.
	MEDPACE HOLDINGS, INC.
	TEMPUS AI, INC.
	EUROFINS SCIENTIFIC SE
	ASCENDIS PHARMA A/S			-
	Average
	Weighted average by Cap.